Pappas Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 6

Professionals

  • Investments
  • 168

  • Portfolio
  • 23

  • Exits
  • 84

Exits

Pappas Capital General Information

Company Description

Founded in 1994, Pappas Capital is a venture capital firm based in Durham, North Carolina. The firm prefers to invest in next-generation life sciences, agriculture, and technology sectors. This firm is a Registered Investment Adviser (RIA).

Business Details

Year Founded
1994
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Corporate Office
  • 2520 Meridian Parkway
  • Suite 400
  • Durham, NC 27713
  • United States
+1 (919)

Pappas Capital Investments (168)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Altay Therapeutics 14-Oct-2026 Later Stage VC Biotechnology Clinical Trials - General
Breye Therapeutics 29-Sep-2026 Drug Discovery Clinical Trials - Phase 2
Aktis Oncology 09-Jan-2026 Drug Discovery Generating Revenue
Solu Therapeutics 09-Apr-2025 Drug Discovery Clinical Trials - Phase 1
VFlow Tech 01-Apr-2025 Electrical Equipment Generating Revenue
Aer Therapeutics 24-Jan-2025 Drug Discovery Clinical Trials - Phase 2
Tune Therapeutics 12-Jan-2025 Biotechnology Clinical Trials - Phase 1
EarthOptics 19-Nov-2024 Business/Productivity Software Generating Revenue
Aktis Oncology 20-Sep-2024 Early Stage VC Drug Discovery Generating Revenue
VFlow Tech 24-May-2024 Later Stage VC Electrical Equipment Generating Revenue
You’re viewing 10 of 168 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pappas Capital Exits (84)

Company Name Exit Date Exit Type Exit Size
Cyclerion 08-Sep-2026 Merger/Acquisition
Istari Oncology 04-Jul-2026
NuProbe 17-Jun-2026
Horizon Quantum Holdings 20-Mar-2026
Avenge Bio 01-Aug-2024
Allievex 24-Jul-2024
Reneo Pharmaceuticals 09-Apr-2021
Amplyx Pharmaceuticals 05-Apr-2021
Vindara 25-Feb-2021 Merger/Acquisition
VelosBio 18-Dec-2020 Merger/Acquisition
You’re viewing 10 of 84 exits. Get the full list »

Pappas Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Pappas Capital‘s full profile, request access.

Request a free trial

Pappas Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Pappas Capital FAQs

  • What is Pappas Capital?

    Founded in 1994, Pappas Capital is a venture capital firm based in Durham, North Carolina.

  • When was Pappas Capital founded?

    Pappas Capital was founded in 1994.

  • Where is Pappas Capital headquartered?

    Pappas Capital is headquartered in Durham, NC.

  • What is Pappas Capital's total asset value?

    Pappas Capital has around in total assets under management.

  • How many investments has Pappas Capital made?

    Pappas Capital has made 168 investments.

  • What has Pappas Capital invested in?

    Pappas Capital has made numerous investments in companies like Altay Therapeutics, Breye Therapeutics, and Aktis Oncology within the Biotechnology and Drug Discovery industries.

  • What has Pappas Capital invested in recently?

    Pappas Capital's latest investment was on 14-Oct-2026 in Altay Therapeutics, a company within the Biotechnology industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process